- Home
- TTNP vs SXTP Comparison
TTNP vs SXTP Comparison
Compare TTNP & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- SXTP
- Stock Information
- Founded
- TTNP 1991
- SXTP 2010
- Country
- TTNP United States
- SXTP United States
- Employees
- TTNP N/A
- SXTP N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- SXTP Health Care
- Exchange
- TTNP Nasdaq
- SXTP Nasdaq
- Market Cap
- TTNP 3.4M
- SXTP 2.4M
- IPO Year
- TTNP 1996
- SXTP 2023
- Fundamental
- Price
- TTNP $3.59
- SXTP $1.75
- Analyst Decision
- TTNP
- SXTP Hold
- Analyst Count
- TTNP 0
- SXTP 1
- Target Price
- TTNP N/A
- SXTP N/A
- AVG Volume (30 Days)
- TTNP 58.6K
- SXTP 80.3K
- Earning Date
- TTNP 03-31-2025
- SXTP 03-31-2025
- Dividend Yield
- TTNP N/A
- SXTP N/A
- EPS Growth
- TTNP N/A
- SXTP N/A
- EPS
- TTNP N/A
- SXTP N/A
- Revenue
- TTNP N/A
- SXTP $462,612.00
- Revenue This Year
- TTNP N/A
- SXTP $150.40
- Revenue Next Year
- TTNP N/A
- SXTP $165.22
- P/E Ratio
- TTNP N/A
- SXTP N/A
- Revenue Growth
- TTNP N/A
- SXTP 128.99
- 52 Week Low
- TTNP $3.03
- SXTP $1.41
- 52 Week High
- TTNP $14.80
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- TTNP 48.42
- SXTP 36.41
- Support Level
- TTNP $3.20
- SXTP $1.41
- Resistance Level
- TTNP $4.39
- SXTP $3.34
- Average True Range (ATR)
- TTNP 0.47
- SXTP 0.21
- MACD
- TTNP -0.05
- SXTP 0.09
- Stochastic Oscillator
- TTNP 30.23
- SXTP 36.56
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.